FOLLOW THE PATENTS: Clear, Logical, Objective tracking of origins of SARS-CoV-2 — It’s not what you think!


In the recently released interview linked below—which consists of a candid question-and-answer interview with David E. Martin, PhD, the founding CEO of M∙CAM Inc.—we at Catholic Business Journal were unanimous in our appreciation for such well-researched, objective, logical and CLEAR tracking of the origins of the SARS-CoV-2 (Covid-19) virus.

The video is a bit long, but absolutely worth it to the end.

We’ve never seen any of this information anywhere else in the news and David E. Martin, PhD — given his extensive research background serving the highest levels of intelligence agencies and his extensive access to data and patents— delivers in a calm, logical way with facts ONLY.

FOLLOW THE PATENTS . . .

Click on the video image below (or here) to watch video

In case you are wondering, below please find more information on David E. Martin, Ph.D, who is featured in the video, and more about his company, culling from the World Intellectual Property Organization for which he has been a speaker..

What is M-CAM, and what does this company do?

M∙CAM is the international leader in intellectual property-based financial risk management.

From auditing patent quality for governments and patent offices, to providing state-of-the-art actuarial risk management systems and solutions to the largest banks and insurance companies, M∙CAM has established a global standard in patent quality and commercial validity assessment and management.

Who is David Martin, PhD?

A spokesperson for global intellectual property accountability and quality reform, Dr. Martin has worked closely with the United States Congress, numerous trade and finance regulatory agencies in the United States, Europe and Asia, in advocating and deploying infrastructure to support growing reliance on proprietary rights in business transactions.

M∙CAM has supported the modernization of intellectual property, tax, and accounting laws through its work with oversight agencies and policy makers.

Dr. Martin has founded several for-profit and non-profit companies and organizations and serves of several boards.

He was the founding CEO of Mosaic Technologies Inc., a company that developed and commercialized advanced computational linguistics technologies, dynamic data compression and encryption technologies, electrical field transmission technology, medical diagnostics, and stealth/anechoic technology. He was a founding member of Japan’’s Institute for Interface Science & Technology.

He founded and served as Executive Director of the Charlottesville Venture Group. He has served as a board member for the Research Institute for Small and Emerging Business (Washington D.C.), the Academy for Augmenting Grassroots Technological Innovations (India), the IST (Japan) the Charlottesville Regional Chamber of Commerce (Virginia), and the Charlottesville Industrial Development Agency (Virginia).

Click on the video image below (or here) to watch video

As former Assistant Professor at the University of Virginia’’s School of Medicine, Dr. Martin founded the University’’s first wholly-owned, for-profit, research and development and technology transfer corporation.

Engaged in domestic and international technology transfer, clinical research and financing, this company pioneered new techniques innovation management that have become industry standards.

In 1999, Dr. Martin was appointed by the Governor of the Commonwealth of Virginia to serve on the Joint Commission on Technology and Science and has served the General Assembly and Virginia’’s Center for Innovative Technology on numerous occasions.

Dr. Martin’’s work with the Batten Institute at the Darden Graduate School of Business Administration at the University of Virginia and his related work at the Indian Institute for Management in Ahmedabad, India, has brought unprecedented curricular focus to areas of intangible asset risk management, finance, and accounting standards.

In addition to his academic work, Dr. Martin has closely advised intellectual property based finance and investment programs in India, China, Denmark, the European Union, the United Kingdom, South Africa, the Islamic Republic of Iran, the United States, and the United Arab Emirates.

Dr. Martin has publications in law, medicine, engineering, finance and education. He maintains active research in the fields of linguistic genomics, fractal financial risk modeling, as well as continuing his over 15 years of research in cellular membrane ionic signaling.

RELATED RESOURCES:

Click on the video image below (or here) to watch video

 

Leave a Reply